Funding opportunities
Open and upcoming programs from Canadian funders and US federal grants (Grants.gov). Deadlines first, then rolling intakes.
Translational Neural Devices (R61/R33 - Clinical Trial Optional)
National Institutes of Health · Deadline 2027-01-28
The purpose of this Notice of Funding Opportunity (NOFO) is to encourage investigators to pursue translational activities and small clinical studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported in this program include implementation of clinical prototype devices, non-clinical safety and efficacy testing, design verification and validation activities, obtaining an Investigational Device Exemption (IDE) for a Significant Risk (SR) study or Institutional Review Board (IRB) approval for a Non-Significant Risk (NSR) study, as well as a subsequent small clinical study. The clinical study is expected to provide information about the device function or final design that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. This NOFO is a milestone-driven cooperative agreement program and will involve participation of NIH program staff in negotiating the final project plan before award and monitoring of research progress.
NIDDK Multi-Purpose Resource-Related, Multi-Component Research Services Centers Cooperative Agreement (U2C - Clinical Trial Optional)
National Institutes of Health · Deadline not published
This Notice of Funding Opportunity (NOFO) announcement invites applications for NIDDK Multi-Purpose Resource-Related Research, Multi-Component Centers Cooperative Agreement (U2C - Clinical Trial Not Allowed). To help increase rigor, reproducibility and cost efficiencies, U2C centers offer highly specialized cores that provide a range of topic focused services including but not limited to hands-on technical services, consulting, research/data coordination, or other research support services provided by nationally recognized experts. In contrast to other types of Core Centers, the U2C services should be largely provided to clients located at another institution where the needed service or expertise is not available. Provided services enable high impact research within NIDDK’s research mission including but not limited to integrative physiology, metabolic phenotyping, nutrition, community engagement, communications, and/or data and research coordination. The disease focus should similarly be within NIDDK’s mission, such as obesity and diabetes. The clients for these services can be a consortia, research partners or individual investigators and should offer experiential training in at
ROSES 2025: A.17 Hydrosphere
NASA Headquarters · Deadline 2027-01-28
The close date above is the date for the Step-2 proposal due date. The Step-1 proposal due date is October 8, 2026 . Step-2 proposals cannot be submitted if a Step-1 proposal was not submitted. NOTICE: September 18, 2026. Several corrections have been made: (1) Information about the 2027–2028 winter field campaign has been updated in Section 5, (2) Details on the redacted and anonymized budget requirements have been added to Table A.17-1, and (3) Text on Biographical Sketches and Current and Pending Support in Table A.17-2 has been improved. New text is in bold and deleted text is struck through NOTICE: Amended September 2, 2026. This amendment adds this new program element to ROSES-2025. Step-1 proposals are due October 8, 2026, and Step-2 proposals are due January 28, 2027 . Any proposal not preceded by an on-time compliant Step-1 proposal will be returned without review . A briefing for potential proposers to this program element will occur Monday, September 14, from 2-3 PM Eastern Time . Connection information will be posted under "other documents" on the NSPIRES page for this program element. Proposals submitted to this program will be evaluated using dual anonymous peer rev
BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System
National Institutes of Health · Deadline not published
The Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative along with other NIH Institutes and Centers (ICs) intends to publish a Notice of Funding Opportunity (NOFO) to encourage investigators to pursue first-in-human or early-stage clinical studies for recording and/or stimulating devices to treat central nervous system disorders and better understand the human brain. This NOFO will be a part of a milestone-driven program, involving collaborative activities with the program officer(s)/director(s) assigned to the funded projects and joint responsibility for the successful management of the program post-award. This NOFO will allow participation in the NIH BRAIN Initiative Public Private Partnership Program which aims to facilitate partnerships between clinical investigators and manufacturers of latest-generation stimulating and/or recording devices to conduct clinical research in the CNS. Through the PPP, the BRAIN Initiative is interested in reducing barriers to negotiating such partnerships and ensuring that new clinical studies leverage manufacturers' existing data. Data demonstrating safety and utility of these devices are very costly to obtain and po
Minor Use Minor Species Development of Drugs (R01)
Food and Drug Administration · Deadline 2027-01-29
This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS). The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs. Only entities developing drugs for veterinary use or parties working as research partners with such entities are eligible for grants. The organization (or applicant) seeking approval of the new animal drug under investigation must have opened an Investigational New Animal Drug (INAD) file with FDA/CVM and must hold a minor use or minor species "designation" granted by FDA/CVM's Office of Minor Use and Minor Species Animal Drug Development (OMUMS) for that drug for a specified intended use, in accordance with the provisions of section 573 of the Food, Drug and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CF Awards up to $250,000.
Immune Tolerance Network (UM1 Clinical Trial Required)
National Institutes of Health · Deadline 2027-01-29
The purpose of this notice of funding opportunity (NOFO) is to support applications to continue the Immune Tolerance Network (ITN). The primary objective of the Network is to develop tolerogenic therapies for immune-mediated disorders. The three main clinical areas of work are: 1) Allergic diseases and asthma; 2) Autoimmune diseases; and 3) Immune-mediated consequences of transplantation. The core functions of the ITN include designing, conducting, and sharing the results of clinical trials and performing integrated mechanistic studies.
Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
National Institutes of Health · Deadline 2027-01-29
The purpose of this notice of funding opportunity (NOFO) is to support a consortium of Translational Centers using Microphysiological Systems (MPS) for Infectious Diseases (TCMID). Recent efforts in the MPS fields are moving towards validation and regulatory use but have not focused upon models studying infectious diseases and testing of medical interventions. The NIH and FDA have recently issued guidance and established initiatives for enhancing use of New Approach Methodologies (NAMs) in research and product development. This includes in vitro systems that allow scientists to model human disease and capture human variability and patient-specific characteristics that will accelerate safer treatments for patients while reducing costs and sparing use of laboratory animals. To meet this need, the Centers will refine well validated human tissue models studying infectious diseases to a level consistent with regulatory qualifications that will promote their adoption for use by product developers, supporting regulatory acceptance.
Health and Extreme Weather Solutions-Focused Research Hubs (U54 - Clinical Trial Optional)
National Institutes of Health · Deadline not published
The National Institute of Environmental Health Sciences (NIEHS) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications that propose translational research hubs with multiple highly integrated components focused on research, capacity building, and community/public health translation for regionally relevant topics related to the health impacts of extreme weather and cumulative exposures, including but not limited to wildfire smoke, extreme heat, flooding, hurricanes, drought, and other climate-related hazards affecting populations at heightened risk across the lifespan. Responsive applications will be led by a multidisciplinary team of investigators with non-academic partners, such as state and local public health departments, community-based organizations, Tribal entities, health care systems, and emergency preparedness agencies. Consortia of multiple institutions are encouraged, particularly those that demonstrate meaningful community engagement and balanced, mutually beneficial partnership structures. Research can be situated at different nodes on the translational research continuum, spanning from fundamental to implementation research with a focus on b Awards up to $2,000,000.
Health and Extreme Weather Research Coordination and Data Center (U2C - Clinical Trial Not Allowed)
National Institutes of Health · Deadline not published
The National Institute of Environmental Health Sciences (NIEHS) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research coordination and data support for the Health and Extreme Weather (HEW) initiative. This solicitation will include two closely aligned components: research coordination and data support. The coordinating component will be responsible for facilitating engagement across the initiative’s NIH grantees and the larger HEW community of practice (CoP). This component will share best practices across the CoP, create training and educational resources, organize working groups and larger meetings, and otherwise disseminate information to the HEW CoP. The data component will develop resources and infrastructure to facilitate access to and use of health and environmental data by the HEW CoP. The data component will identify data-related needs in the CoP, provide training to address these needs, support sharing and linking of health, environmental, and geospatial data, and collaborate with other NIH data initiatives to reduce duplication, advance data science, and promote the use of data standards and harmonization. The coordinating and dat
NIOSH Mentored Research Scientist Development Award (K01)
Centers for Disease Control and Prevention - ERA · Deadline not published
The National Institute for Occupational Safety and Health (NIOSH) K01 grant provides "protected time" for a supervised career development experience in occupational health and safety research. NIOSH supports the mentoring of junior investigators during the critical transition from postdoctoral training to securing independent R01 funding. We hope to foster investigators' careers, who are vital for occupational safety and health's future. Applicants must justify why they need mentored research and describe how the support will enhance their independence. Awards range from $50,000 to $100,000.
KUH P30 Resource Core Center (P30 Clinical Trial Not Allowed)
National Institutes of Health · Deadline not published
This Notice of Funding Opportunity (NOFO) requests applications for Resource Core Centers within the mission of NIDDK/Kidney, Urology, and Hematology (KUH) Diseases. Each Center is designed to advance national research efforts by sharing unique research resources (e.g., data, reagents, models, tools, services, expertise) with the broader community. The Resource Core Centers are expected to work collaboratively with a Center Coordinating Hub (U24) to form a national network.
KUH U24 Center Coordinating Hub (U24 Clinical Trial Not Allowed)
National Institutes of Health · Deadline not published
This Notice of Funding Opportunity (NOFO) requests applications for Center Coordinating Hubs within the mission of NIDDK/Kidney, Urology, and Hematology (KUH) Diseases. Each Center Coordinating Hub will work collaboratively with a national network of funded Centers to develop and share unique research resources (e.g., data, reagents, models, tools, services, expertise) with the broader community.
Training and Employment Guidance Letter (02-26) for FY 2026 Community Project Funding/Congressionally Directed Spending
Employment and Training Administration · Deadline 2027-01-31
Questions regarding this Training and Employment Guidance Letter may be emailed to Community.Projects.ETA@dol.gov. We encourage FY2026 sponsored recipient organizations to use the Grants.gov subscription option to register for future updates provided for this particular TEGL. Awards range from $50,000 to $5,320,000.
Agriculture Innovation Center Grant Program
Rural Business-Cooperative Service · Deadline 2027-01-31
The primary objective of the program is to provide grants to Agriculture Innovation Centers that will provide technical assistance to agricultural producers to market value-added agricultural products. Awards range from $600,000 to $1,000,000.
Biological Anthropology Program Senior Research Awards (BA-SR)
U.S. National Science Foundation · Deadline 2027-02-01
The Biological Anthropology Program seeks to advance scientific knowledge about the processes that have shaped biological diversity in living and fossil humans and their primate relatives through support of basic research on human and primate evolution, biological variation, and interactions between biology, behavior, and culture. The program supports a portfolio of research that demonstrates engagement with biological anthropological and evolutionary theory; includes diverse and interdisciplinary methods in field, laboratory and computational settings; encompasses multiple levels of analysis (e.g., molecular, organismal, population, ecosystem) and time scales from the short-term to evolutionary; and considers the ethical implications and societal impacts of the research. The program also supports a wide range of broader impact activities as part of research grants, including research outcomes with inherent benefit to society, efforts to broaden participation in science, technology, engineering, and mathematics (STEM) research, training and outreach activities and other evidence-based activities developed within the context of the mission, goals, and resources of the organizations
Cognitive Neuroscience (CogNeuro)
U.S. National Science Foundation · Deadline 2027-02-01
The Cognitive Neuroscience (CogNeuro) program seeks to fund proposals that can advance our understanding of the neural mechanisms underlying human cognition and behavior. Funded proposals typically relate precise and rich quantifications of physiological responses and behavior in ways that advance theory (Intellectual Merit). Funded proposal also typically strengthen the field through, for example, outreach, mentoring the next generation of diverse cognitive neuroscientists, and/or increasing awareness and utilization of the research the field produces (Broader Impacts). Intellectual Merit In general, successful proposals provide a theoretical motivation and consist of a series of experiments/analyses that test the differential predictions of that theory; they go beyond quantifying physiology during certain tasks and behaviors. Research topics considered for funding include but are not limited to: perception, recognition, categorization, implicit and explicit memory, working memory, attention, language, decision-making, and social reasoning. Commensurate with the inherently multidisciplinary nature of the field and the limitations of any single technique, a wide variety of physiolo
Developmental Sciences (DS)
U.S. National Science Foundation · Deadline 2027-02-01
Developmental Sciences supports basic research that increases our understanding of perceptual, cognitive, linguistic, social, cultural, and biological processes related to human development across the lifespan. Research supported by this program will add to our knowledge of the underlying developmental processes that support social, cognitive, and behavioral functioning, thereby illuminating ways for individuals to live productive lives as members of society. The Developmental Sciences program supports research that addresses developmental processes within the domains of perceptual, cognitive, social, emotional, language, and motor development across the lifespan by working with any appropriate populations for the topics of interest including infants, children, adolescents, adults (including aging populations), and non-human animals. The program also supports research investigating factors that affect developmental change, including family, peers, school, community, culture, media, physical, genetic, and epigenetic influences. The program funds research that incorporates multidisciplinary, multi-method, and/or longitudinal approaches; develops new methods, models, and theories for
Early Detection, Response, and Control of Global Rabies Outbreaks and Associated Threats to America's Dog-Rabies Free Status
Centers for Disease Control and Prevention - ERA · Deadline not published
This Notice of Funding Opportunity (NOFO) supports research to develop, implement, monitor, and evaluate technology-driven and cost-effective tools that reduce the global human rabies burden. It also measures progress toward canine rabies elimination, with an emphasis on high-burden countries. Priority research areas include: Electronic systems for tracking human and dog rabies vaccinations. Managing human rabies exposure investigations. Enhancing rabies laboratory information management systems. Modeling the economic impact of dog-mediated rabies interventions. Estimating rabies-susceptible dog populations. The research is intended to generate data-driven strategies that help accelerate progress toward global canine rabies elimination and protect public health. Awards range from $150,000 to $400,000.
RNomics Technology Enhancement Centers
National Institutes of Health · Deadline not published
The NIH Common Fund, in partnership with other NIH Institutes and Centers, plans to issue Notices of Funding Opportunity (NOFOs) for the RNomics program, which seeks to develop tools for studying the full set of RNA molecules (the RNome) in cells and tissues. The program will support technologies and resources that enable integrated analysis of RNA sequences, modifications, structures, locations, interactions, and functions to advance understanding of health and disease. RNomics includes four initiatives: technology enhancement centers, transformative technologies, molecular standards, and a coordinating center. Applications are not being solicited at this time. This notice is being provided to give potential applicants time to develop meaningful collaborations and strong projects. This NOFO will establish collaborative RNomics Technology Enhancement Centers (RTECs). RTECs will further develop existing technologies with demonstrated feasibility. These centers will strengthen experimental and computational tools for measuring, mapping, and testing RNA in cells and tissues, with the goal of delivering measurable improvements and supporting broad community use. Priority areas include Awards up to $2,000,000.
RNomics Outreach and Coordination (ROC) Center
National Institutes of Health · Deadline not published
The NIH Common Fund, in partnership with other NIH Institutes and Centers, plans to issue Notices of Funding Opportunity (NOFOs) for the RNomics program, which seeks to develop tools for studying the full set of RNA molecules (the RNome) in cells and tissues. The program will support technologies and resources that enable integrated analysis of RNA sequences, modifications, structures, locations, interactions, and functions to advance understanding of health and disease. RNomics includes four initiatives: technology enhancement centers, transformative technologies, molecular standards, and a coordinating center. Applications are not being solicited at this time. This notice is being provided to give potential applicants time to develop meaningful collaborations and strong projects. This NOFO will establish the RNomics Outreach and Coordination (ROC) Center. The ROC Center will serve as the consortium's hub for data management, coordination, and community engagement. It will develop a central RNomics data portal, support the development and use of data standards, coordinate technology validation and benchmarking, lead consortium-wide data analysis, and support outreach, training, an